Brighton Jones LLC Novo Nordisk A S Transaction History

Brighton Jones LLC

  • $2.96 Billion
  • Q1 2025

A detailed history of Brighton Jones LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Brighton Jones LLC holds 13,763 shares of NVO stock, worth $926,938. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,763
Previous 14,137 2.65%
Holding current value
$926,938
Previous $1.22 Million 21.46%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 17, 2025
SELL
$69.3 - $90.95 $25,918 - $34,015
-374 Reduced 2.65%
13,763 $955,000
Q4 2024

Mar 04, 2025
SELL
$85.0 - $120.04 $88,315 - $124,721
-1,039 Reduced 6.85%
14,137 $1.22 Million
Q4 2024

Jan 17, 2025
SELL
$85.0 - $120.04 $88,315 - $124,721
-1,039 Reduced 6.85%
14,137 $1.22 Million
Q3 2024

Mar 04, 2025
BUY
$119.07 - $145.42 $72,156 - $88,124
606 Added 4.16%
15,176 $1.81 Million
Q3 2024

Oct 22, 2024
BUY
$119.07 - $145.42 $72,156 - $88,124
606 Added 4.16%
15,176 $1.81 Million
Q2 2024

Mar 04, 2025
BUY
$122.71 - $146.91 $53,133 - $63,612
433 Added 3.06%
14,570 $2.08 Million
Q2 2024

Aug 12, 2024
BUY
$122.71 - $146.91 $690,243 - $826,368
5,625 Added 62.88%
14,570 $2.08 Million
Q1 2024

May 09, 2024
BUY
$102.11 - $135.92 $115,792 - $154,133
1,134 Added 14.52%
8,945 $1.15 Million
Q4 2023

Feb 05, 2024
BUY
$87.78 - $105.45 $43,977 - $52,830
501 Added 6.85%
7,811 $808,000
Q3 2023

Oct 25, 2023
BUY
$90.94 - $199.54 $400,590 - $878,973
4,405 Added 151.64%
7,310 $664,000
Q2 2023

Jul 31, 2023
BUY
$155.98 - $172.65 $39,618 - $43,853
254 Added 9.58%
2,905 $470,000
Q1 2023

May 08, 2023
BUY
$132.34 - $159.14 $4,367 - $5,251
33 Added 1.26%
2,651 $421,000
Q4 2022

Feb 02, 2023
SELL
$102.55 - $135.33 $13,741 - $18,134
-134 Reduced 4.87%
2,618 $354,000
Q3 2022

Nov 09, 2022
BUY
$95.28 - $116.93 $40,398 - $49,578
424 Added 18.21%
2,752 $274,000
Q2 2022

Aug 04, 2022
BUY
$103.24 - $121.81 $3,510 - $4,141
34 Added 1.48%
2,328 $259,000
Q1 2022

May 13, 2022
BUY
$93.1 - $112.54 $3,444 - $4,163
37 Added 1.64%
2,294 $255,000
Q4 2021

Feb 03, 2022
BUY
$95.88 - $117.08 $216,401 - $264,249
2,257 New
2,257 $253,000
Q4 2018

Feb 08, 2019
SELL
$41.54 - $47.25 $208,946 - $237,667
-5,030 Closed
0 $0
Q3 2018

Nov 07, 2018
BUY
$46.76 - $51.24 $235,202 - $257,737
5,030 New
5,030 $237,000

Others Institutions Holding NVO

# of Institutions
1,768
Shares Held
330M
Call Options Held
11.3M
Put Options Held
15.5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $152B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email